Lars Christian Wilde

Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA.

Vium, Inc. provides technology for preclinical drug discovery services. It offers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. The company was founded by Timothy L. Robertson and Jonathan Betts-Lacroix in 2013 and is headquartered in San Mateo, CA.

The New York Academy of Medicine (NYAM) is a leading advocate for innovation in public health. The non-profit company is based in New York, NY and has subsidiaries in the United States. For 176 years, NYAM has been at the forefront of promoting bold changes to the systems that perpetuate health inequities and prevent communities from achieving good health. NYAM's work includes innovative research, programs, and policy initiatives that value community input for maximum impact. NYAM's library is one of the most significant historical libraries in medicine and public health in the nation, with an extensive range of recommended resources available.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

CellMedical SA operates medical diagnostic laboratories. The company is headquartered in Thessaloniki, Greece.

Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom.

NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden.

Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom.

Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia.

Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom.

Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014.

Coqual, formerly known as the Center for Talent Innovation, is a nonprofit think tank that helps leaders create diverse, equitable, and inclusive workplaces. The non-profit company is based in New York, NY, and was founded by Sylvia Ann Hewlett. The company focuses on conducting cutting-edge research and providing advisory services on various identities, including gender, race, ethnicity, disability, veteran status, and LGBTQ. Coqual was founded in 2004 and offers in-depth research, thought leadership, and data-driven solutions to address bias and barriers to inclusion for underrepresented populations in the workplace. Lanaya Irvin has been the CEO of the company since 2020.

PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom.

iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom.

Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA.

PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme.

AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA.

The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products.

ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.

Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017.

The Conduit Connect Ltd. is a private membership platform for high net worth, sophisticated, and professional impact investors. The company is based in London, UK. The British company connects founders who are building scalable, for-profit, impact-driven businesses to capital and expert resources. The company source and connects the most promising high growth impact investing opportunities to mission-aligned investors. The company was founded in 2018, and the CEO is Eva-Maria Dimitriadis.

Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010.